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Abstract
Case-control studies have consistently associated psychosocial factors with chronic pain in
general, and with temporomandibular disorders (TMD) specifically. Moreover, a handful of
prospective studies suggest that pre-existing psychosocial characteristics represent risk factors for
new onset TMD. The current study presents psychosocial findings from the baseline case-control
study of the Orofacial Pain Prospective Evaluation and Risk Assessment (OPPERA) cooperative
agreement. For this study, 1,633 TMD-free controls and 185 TMD cases completed a battery of
psychosocial instruments assessing general psychosocial adjustment and personality, affective
distress, psychosocial stress, somatic awareness, and pain coping and catastrophizing. In bivariate
and demographically-adjusted analyses, odds of TMD were associated with higher levels of
psychosocial symptoms, affective distress, somatic awareness, and pain catastrophizing. Among
controls, significant gender and ethnic group differences in psychosocial measures were observed,
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consistent with previous findings. Principal component analysis was undertaken to identify latent
constructs revealing four components: stress and negative affectivity, global psychosocial
symptoms, passive pain coping, and active pain coping. These findings provide further evidence
of associations between psychosocial factors and TMD. Future prospective analyses in the
OPPERA cohort will determine if the premorbid presence of these psychosocial factors predicts
increased risk for developing new-onset TMD.
Keywords
temporomandibular disorders; psychosocial risk factors; chronic pain; somatic awareness;
catastrophizing
Introduction
Abundant evidence demonstrates that psychosocial factors contribute importantly to the
experience of pain. In numerous case-control studies, investigators have reported that
compared with pain-free controls, patients with chronic pain conditions show elevations on
measures of psychosocial distress, environmental stress, catastrophizing, and somatic
awareness, and these psychosocial variables are associated with poorer pain-related
adjustment among patients with chronic pain 20,31,35. In addition to these findings related to
chronic pain in general, similar results have been reported in patients with
temporomandibular disorders (TMD)25,70. For example, relative to pain-free populations,
patients with TMD have reported higher levels of affective distress,9,10,50 somatic
awareness,47,51 psychosocial stress, 13,48 and pain catastrophizing.8,67 Also, personality
characteristics, such as neuroticism, have been found to differ for TMD cases versus
controls.29,61 Recently, neuroticism was linked to increased gray matter thickness in the
prefrontal cortex in TMD patients,55 perhaps implicating neuroticism in cortical changes
associated with altered pain processing in TMD. Further evidence of the importance of
psychosocial factors in TMD derives from studies demonstrating an association between
psychosocial measures and both the severity and persistence of TMD-related clinical
symptoms. Specifically, cross-sectional studies show that higher levels of psychological
distress are related to increased TMD pain and disability,6,51,86 and longitudinal designs
have demonstrated that psychosocial factors, such as somatic awareness and depression,
represent risk factors for long-term persistence of TMD pain.26,30,58
While the above findings clearly demonstrate the clinical relevance of psychosocial factors
in TMD, whether TMD pain drives psychological symptoms, or vice versa, is difficult to
determine from studies of established TMD cases. Several prospective studies have
demonstrated that pre-existing psychosocial factors predict the development of new onset
chronic pain conditions, including chronic widespread pain,53 regional musculoskeletal
pain,57 and low back pain.43,44,57 However, few investigators have examined the role of
psychosocial factors in predicting new onset TMD using prospective cohort designs. Slade
and colleagues 75 assessed psychosocial factors in healthy females and followed them for a
three-year period, during which time 8.8% of the sample developed new onset TMD pain.
Regression models revealed that measures of depression, perceived stress, and mood state
obtained at baseline were significant predictors of new onset TMD. A subsequent
prospective study by Aggarwal et al.1 showed that health anxiety assessed at baseline
predicted risk for development of chronic orofacial pain over the ensuing two-year period.
Thus, a paucity of prospective studies has examined whether premorbid psychosocial factors
are associated with increased risk of TMD onset.
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In addition to psychosocial variables, demographic factors have been associated with TMD
risk. Specifically, sex differences in TMD are well-documented, as women are significantly
more likely to be diagnosed with TMD than men. 18,42 Moreover, TMD prevalence varies
with age, with peak prevalence occurring between the ages of 20 and 40, and lower
prevalence observed in childhood and in older adults.18,42 Ethnic and racial differences in
TMD have also been identified in a handful of studies, for example, with African Americans
showing lower prevalence rates than whites, especially in young adults.34,66 It is notable that
many of the psychosocial factors that have previously been related to TMD are also
associated with demographic factors. For instance, compared to males, females report higher
levels of psychological distress, somatic awareness, psychosocial stress, and
catastrophizing.3,4,23,76 This raises the possibility that the association of demographic
factors with TMD could be mediated by psychosocial variables. Therefore, we report
analyses examining gender, age, and ethnic/racial differences in psychosocial variables.
Given the findings described above, the assessment of psychosocial factors would be an
integral component of any study designed to identify risk factors for onset and persistence of
TMD. The Orofacial Pain Prospective Evaluation and Risk Assessment (OPPERA) study is
a prospective cohort study that endeavors to discover causal determinants of TMD pain. The
design of OPPERA is based on a conceptual model that hypothesizes that psychosocial
factors represent a critically important intermediate phenotypic risk factor for development
of TMD.17 The findings presented below are restricted to the baseline assessment of
psychosocial variables in a large group of people with examiner-classified TMD arthralgia,
myalgia, or both (“TMD cases”) and people who were found not to have TMD when
examined (“controls”). The primary aim of this study was to characterize differences in
psychosocial functioning across multiple psychosocial domains between TMD cases and
controls. In order to accomplish this, a battery of psychosocial instruments was
administered, with the goal of assessing psychosocial functioning across several domains
that have been associated with chronic pain in previous research. Specifically, we included
measures of personality and global psychological adjustment, mood and affect, psychosocial
stress, somatic awareness, and pain coping and catastrophizing. While previous research has
identified a variety of psychosocial variables that may be associated with TMD, few studies
have assessed this broad array of psychosocial factors and determined their relationship
specifically with TMD. A secondary aim of the study was to identify latent constructs across
the multiple psychosocial measures that were administered. To that end, we conducted




As described elsewhere,74 the OPPERA baseline case-control study used advertisements,
emails, flyers and word-of-mouth to recruit people who had chronic TMD (TMD cases) and
people who did not (controls). They were recruited between May 2006 and November 2008
from communities in and around academic health centers at four US study sites: Baltimore,
MD; Buffalo, NY; Chapel Hill, NC; and Gainesville, FL. At each study site, the target was
to recruit 800 controls and variable numbers of cases based on local operational
requirements, for a total of 3,200 controls and 200 cases. The actual number enrolled was
3,263 controls and 185 cases.
The classification of TMD was based on the Research Diagnostic Criteria for
Temporomandibular Disorder.21 In summary, cases met all three of the following criteria:
during the telephone interview, (i) pain reported with sufficient frequency in the cheeks, jaw
muscles, temples, or jaw joints during the preceding six months (at least 15 days in the
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preceding month and at least five days per month in each of the five months preceding that);
during the examination, (ii) pain reported in the examiner-defined orofacial region for at
least 5 days out of the prior 30 days; and (iii) pain reported in at least three masticatory
muscles or at least one temporomandibular joint in response to palpation of the orofacial
muscles or maneuver of the jaw. Examiners defined the orofacial region by touching the
following anatomical areas bilaterally: temporalis, preauricular, masseter, posterior
mandibular, and submandibular. Controls met all six of the following criteria: during the
telephone interview, (i) pain reported infrequently in the cheeks, jaw muscles, temples, or
jaw joints (no orofacial pain in the preceding month and no more than four days per month
in any of the five months preceding that); (ii) no more than four headaches per month within
the preceding three months; (iii) never diagnosed with TMD; (iv) no use of night guard
occlusal splint; and during the examination, (v) pain reported in the examiner-defined
orofacial region for no more than 4 days in the prior 30 days; (vi) classified as having
neither myalgia nor arthralgia. However, controls could be positive or negative with respect
to pain in response to palpation or jaw maneuver. Additional study-wide criteria for all study
participants were aged 18–44 years, fluent in English, not receiving orthodontic treatment,
and not pregnant or nursing, and had negative responses to each of 10 questions about
significant medical conditions and no history of facial injury or surgery. Cases and controls
were not matched in this study. As reported by Slade, et al74, cases were more likely to be
female, non-Hispanic white, and were older than controls. All statistical case-control
comparisons of psychosocial variables controlled for gender, ethnic group, and age
(described below). Cases were also more highly educated than controls, but cases and
controls were similar in socioeconomic variables.
This analysis uses data from all 185 recruited TMD cases and one half of the 3,263 recruited
controls (1,633 people). The controls for this analysis were randomly selected so that data
from participants in the reserved sample could be used for validation studies that will be
reported elsewhere. The accompanying paper74 gives a more detailed account of study
recruitment, case-classification methods, and inclusion and exclusion criteria.
The OPPERA Study was reviewed and approved by institutional review boards at each of
the four study sites and at the data coordinating center, Battelle Memorial Institute. All study
participants verbally agreed to a screening interview done by telephone and they provided
informed, written consent for all other study procedures. This study was conducted under the
auspices of a Certificate of Confidentiality.
Psychosocial Instruments
For all instruments, participants had the option to complete the questionnaire via paper form
or electronic PDF version. To distribute participant burden, some questionnaires were
completed before the clinic visit (pre-clinic), while others were completed in-clinic
immediately before the clinical examination. Missing questionnaire items were imputed
using the expectation-maximization (EM) algorithm as described below. In general, if a
subject skipped at least one but less than half the items in a questionnaire, the missing items
were imputed. If they failed to complete at least half of the items in the questionnaire, we
treated their summary score as missing. Information on missing values and imputation is
provided in Supplementary e-Table 1.
Global Measures of Psychological Function
Eysenck Personality Questionnaire-Revised (Short Form, EPQ-R)—This 57-item
true-false instrument assesses three personality dimensions: Extraversion, Neuroticism, and
Psychoticism. The EPQ-R also includes a Lie scale, which reflects an effort to present
oneself in the most positive light. Factor analysis of the EPQ-R supports the four scales, and
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internal consistency of each of the scales is acceptable, with Cronbach’s alpha ranging from
0.73 to 0.90.28 Scales derived from the 57-item EPQ-R Short Form were found to correlate
highly with scale scores from the original EPQ-R, with correlation coefficients ranging from
0.89 to 0.96 27. The EPQ has been widely used in previous research in chronic pain
populations,5,14,33,80 including TMD.38,39
Symptom Checklist 90-Revised (SCL-90R)—This 90-item instrument evaluates a
broad range of psychological symptoms by having participants report the extent to which
they have been bothered by each symptom on a five-category scale (not at all, a little bit,
moderately, quite a bit, extremely). The SCL-90R provides measures of psychological
distress across the following nine subscales: Somatization, Obsessive-Compulsive,
Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation,
and Psychoticism.16 It also yields three Global Indices: the Global Severity Index (GSI), the
Positive Symptom Distress Index (PSDI), and Positive Symptom Total (PST). This
instrument has demonstrated good internal consistency (Cronbach’s alpha for subscales
ranging from 0.77 to 0.90) and test-retest reliability, which ranged from 0.78 to 0.90.16 The
SCL-90R has been widely used in research with numerous pain conditions,2,12,62,64,73
including TMD.37,41,59,82
Measures of Affective Distress
State-Trait Anxiety Inventory (STAI)—The STAI includes two 20 item questionnaires,
the State Anxiety Inventory and the Trait Anxiety Inventory.77 For each item, participants
are asked to indicate either how they “generally feel” (trait anxiety) or how they “feel right
now” (state anxiety) using a four-category scale (not at all, somewhat, moderately so,
extremely so). Test-retest reliability for the Trait Anxiety Scale has been adequate, ranging
from 0.73 to 0.86 over intervals of 20 to 104 days.77 As expected, State Anxiety is
significantly less stable over time, given the transitory nature of anxiety states. Internal
consistencies for both scales were high, with Cronbach’s alphas of greater than 0.90.77
The Profile of Mood States-Bipolar (POMS-Bi)—This instrument consists of 72
mood-related items, and participants indicate the extent to which each item describes their
mood state over the past week, including today using a four-category scale (much unlike
this, slightly unlike this, slightly like this, much like this). This questionnaire assesses both
positive and negative affective dimensions. It yields six subscale scores (Agreeable-Hostile,
Elated-Depressed, Confident-Unsure, Energetic-Tired, Clearheaded-Confused, Composed-
Anxious), as well as global indices of positive affect and negative affect. Given the state-like
nature of the measure, test-retest reliabilities are understandably modest in magnitude,
ranging from 0.33 to 0.72. The POMS has been well validated with other mood measures
and is sensitive to subtle differences in affective state.46
Measures of Psychosocial Stress
The Perceived Stress Scale (PSS)—This 10-item scale assesses the perception of
stress, that is, the degree to which an individual appraises situations as stressful 11. For each
item, participants indicate how often they felt or thought that way in the past month using a
five-category scale (never, almost never, sometimes, fairly often, very often). The PSS
yields a single overall perceived stress score by summing the numerical weights of each
item, after reverse scoring four of the items. Internal consistency is good with Cronbach’s
alpha of 0.84 or greater, and construct validity has been demonstrated, as the PSS correlates
significantly with other measures of stress appraisal.11
The Life Experiences Survey (LES)—This 57-item instrument assesses the frequency
of life events that have occurred over the past year, as well as the impact of these events 72.
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Impact ratings range from −3 (extremely negative) to +3 (extremely positive), with 0
indicating “no impact.” There are multiple approaches to scoring the LES, which generally
yield measures of frequency of positive, negative, and total events as well as positive,
negative, and total impact of events. The test-retest reliability of positive impact was
reported as low (0.10 and 0.53 across two samples), while reliabilities for negative and total
impact were adequate, ranging from 0.56 to 0.88. Previous research indicated that scoring of
impact based on individualized weights (i.e., each respondent’s rating of impact) was the
best predictor of psychological distress.87 therefore, we report impact scores based on
individualized weights in the included tables. For the LES, subjects who endorsed 40 or
more items were excluded, on the grounds that they likely misunderstood the instructions for
the questionnaire. Others were excluded from LES scoring if their answers were
inappropriate based on their gender. (For example, male respondents who reported a
pregnancy in the previous year were discarded.) This resulted in missing data for 240
participants (18 cases, 222 controls) on the LES. Frequency data and impact scores can be
found in Supplementary e-Table 3.
The Lifetime Stressor List/PTSD Checklist-Civilian Version (LSL/PCL-C)—The
LSL presents a checklist of 15 different traumatic events, and participants indicate which (if
any) of these events they have experienced. For participants who endorse at least one item,
they are then asked to identify the most significant stressor, and they complete the remaining
17-items regarding the extent to which they experience PTSD symptoms (e.g., repeated,
disturbing memories of the experience) related to the selected traumatic event. Each item is
endorsed on a five-category scale (not at all, a little bit, moderately, quite a bit, extremely).
A total score is derived by summing the scores from each of the 17 symptoms. Test-retest
reliability is high (0.96), and internal consistency ranged from 0.89 to 0.92.84 In our sample,
912 controls and 83 cases did not endorse any traumatic events; therefore, PCL-C scores for
these participants were set to missing.
Measures of Somatic Awareness
The Pennebaker Inventory of Limbic Languidness—(PILL) assesses the frequency
with which individuals are bothered by each of 54 common physical symptoms and
sensations on a five-category scale (never or almost never, less than 3 or 4 times a year,
every month or so, every week or so, more than once every week). A single summary score
is derived by summing each of the individual item responses, and PILL scores are related to
the construct of somatic awareness or the general tendency to endorse physical symptoms.
High internal consistency (alpha = 0.88) and adequate test-retest reliability (0.70 over two
months)63 have been reported. The PILL has been used as a measure of hypervigilance in
fibromyalgia patients, who demonstrated higher scores on the PILL compared to arthritis
patients and pain-free controls.54
The Kohn Reactivity Scale.40—This instrument consists of 24 items that assess an
individual’s level of reactivity or central nervous system arousability. Individuals respond to
each item on a five-category scale ranging from “disagree strongly” to “agree strongly.” The
Kohn yields a single summary score created by summing all of the items, after reverse
scoring half of the items. This measure has been reported to have adequate internal
consistency, ranging from alpha of 0.73 to 0.83.40 The Kohn has been shown to correlate
negatively with pain tolerance 19 and it has been used as a measure of the construct of
hypervigilance.54
Measures of Coping/Catastrophizing
The Coping Strategies Questionnaire-Revised (CSQ-R)—This CSQ-R is a revised
version of the original CSQ,71 which consists of 27 items relating to how individuals cope
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with pain. Participants indicate the frequency with which they engage in specific coping
activities when experiencing pain using a seven-category numerical scale, ranging from 0
(never do that) to 6 (always do that). It yields six subscales reflecting the pain coping
strategies that individuals use: diverting attention, catastrophizing, praying and hoping,
ignoring pain sensations, reinterpreting pain sensations, and coping self-statements. The
subscales have shown adequate internal consistency, with Cronbach’s alpha ranging from
0.72 – 0.91 in a sample of healthy young adults.32 The CSQ-R has been shown to have
stable factor structure in patients with chronic pain 69 and in healthy populations.32 Because
the catastrophizing scale from the CSQ-R is identical to the Helplessness scale from the PCS
(see below), the CSQ-R’s catastrophizing scale was excluded from all analyses.
The Pain Catastrophizing Scale (PCS)—This instrument consists of 13 items rated on
a 5-point scale ranging from 0 (not at all) to 4 (all the time). Participants indicate the degree
to which they have specified thoughts and feelings when experiencing pain. The measure
assesses three dimensions of catastrophizing: Rumination, Magnification, and Helplessness,
and a total score is calculated by summing the three subscales. Internal consistency has been
shown to be adequate to very good, with coefficient alphas ranging from 0.66 to 0.87 across
subscales.78 The PCS has been validated for both clinical and nonclinical samples.60,78
Additional Measures
The Pittsburgh Sleep Quality Index (PSQI)—The PSQI is the most commonly
administered self-report sleep measure. This 19-item instrument assesses sleep quality
during the previous month across the following domains: Subjective Sleep Quality, Sleep
Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disturbances, Use of Sleep
Medications, and Daytime Dysfunction.7 Internal consistency was found to be high, with
Cronbach’s alpha of 0.83, and test-retest reliability for Global PSQI scores was 0.85 7. The
PSQI has been used in previous research to identify sleep disturbance associated with
TMD.15,86 For the PSQI, errors in subjects’ reporting of time values were corrected by
algorithm (e.g. when 12:00 AM was confused with 12:00 PM or reporting 40:00 PM instead
of 4:00 PM). For subjects who reported hours of sleep but not minutes, the value for minutes
was set to 0.
The Medical Outcomes Study Short Form 12 Item Version (SF-12)—The SF-12 is
a briefer measure of health-related quality of life derived by using 12 items from the original
SF-36 instrument.83 The SF-12 yields two scale scores, A Mental Health Composite Score
(MCS) and a Physical Health Composite Score (PCS), which correlate highly with the MCS
and PCS scores from the original SF-36, and test-retest reliability for the PCS and MCS
measures ranged from 0.76 to 0.89. 83 The SF-12 has been found to distinguish patients with
chronic pain conditions from healthy controls.45,52
Data Analysis
For the instruments with reversed scored items (KOHN, PSS, POMS-Bi, STAI), responses
for the subjects who endorsed all minimum or all maximum values were considered invalid
and set to missing. Imputation for missing values used the EM method in SAS proc MI,
which finds maximum likelihood estimates for incomplete data under the assumption that
the data are multivariate normal. Descriptive statistics for each summary score were
generated using non-imputed data. Statistical significance of differences in mean scores was
evaluated using the t-test derived from a least squares linear model in which study site was a
covariate. Study site was used as a covariate because operational requirements during
recruitment created different proportions of cases among sites (see Slade, et al.74 for further
detail). The relationship between each summary score and occurrence of TMD was
expressed as the standardized odds ratio, calculated from an unconditional, binary logistic
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regression model with study site as a covariate. To achieve this, the summary score was
transformed to a unit-normal deviate. The transformation meant that odds ratios could be
interpreted as the relative change in odds of TMD for each standard deviation of change in
the summary score. A second logistic regression model generated a fully-adjusted estimate
of the relationship, using additional covariates of age (in years) gender and race/ethnicity
(dichotomized as white or non-white). A third logistic regression model using this imputed
dataset calculated standardized odds ratios for each summary score, with adjustment for the
same covariates as in the prior model.
All P-values were computed without adjustment for multiple tests, and we therefore refrain
from nominating P=0.05 as a threshold for statistical significance. In this paper’s case-
control analysis, 21 psychosocial characteristics were investigated and, therefore, Bonferroni
correction for the probability of type I error would yield a critical P value of 0.05/21 =
0.002. Using the same rationale, rejection of the null hypothesis concerning odds ratios
would occur only if the 99.8% confidence interval excluded the null value of one. In
general, though, we avoid drawing conclusions about statistical significance of associations,
even with correction for multiple tests, because these papers report only univariate- or
demographically-adjusted results. Furthermore, the Bonferroni adjustment is probably
overly-conservative in this setting, where several measures are moderately correlated.
Instead, we will reserve judgments about statistical significance to subsequent papers that
will use multivariable modeling to consider multiple characteristics simultaneously, as
proposed in the OPPERA heuristic model.49
Principal component analysis (PCA) was applied to this data set to identify putative latent
variables, which potentially could serve in the future as a reduced set of variables to be
exploited in multivariate analyses. The approach began with four steps, widely used in
exploratory principal component analysis:65 (1) variable selection; (2) evaluation of the
correlation matrix; (3) extraction of initial components; and (4) rotation and interpretation of
component loadings. This model is being used for purely exploratory purposes with regards
to the structure of the latent variables and not for computation of summary scores for the
various components.
Our primary interest focused on PCA loadings in controls for three reasons: (a) there are
many more controls than cases, thereby improving statistical power to identify factors and
estimate loadings; (b) our underlying conceptual model of TMD49 proposes that
relationships between putative risk factors might alter following onset of chronic pain, and
we wanted to evaluate that possibility; and (c) the long-term goal of OPPERA is to identify
risk factors for TMD among controls, so it is desirable to identify a reduced set of variables
for that group. Thus, we fit separate PCA models for the TMD cases and controls.
Variables were selected for this analysis based primarily on conceptual grounds.
Specifically, those measures that have been previously associated with TMD in case-control
studies and were specified a priori in the OPPERA conceptual model49 were included in the
PCA. On this basis, the PSQI and SF-12 were excluded. Due to high levels of missingness
(as described above), the LES and LSL/PCL-C were excluded. The variables included in the
model are shown in Table 4. We elected to keep all 21 variables in the model even though
some of the variables were highly correlated with one another. We wanted to see which
measures could be combined into latent variables, and this required that all the variables be
retained in the exploratory model. Although this has the potential to increase the variance of
our estimates of the PCA loadings, this was not a major concern given our large sample size.
As shown below, we estimated the variance of our PCA loadings using bootstrapping, and
these variances were uniformly low despite the correlations among the input variables.
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After imputing missing values as described above, 50 subjects still had at least one missing
value among the variables included in the model. To retain these subjects in the model, we
performed a second round of imputation. Specifically, we imputed any missing scale scores
based on the observed scale scores from the remaining instruments for each participant. (We
used the EM algorithm to perform this imputation under the assumption that the data are
multivariate normal, as described previously.) After performing this second round of
imputation, there were no remaining subjects with missing data.
PCA models were fit using the R statistical computing platform. All variables were
normalized to have mean 0 and standard deviation 1 prior to fitting the models. Eigenvalues
from the initial, unrotated solution were inspected using a scree plot. To help determine the
optimal number of eigenvectors, a parallel analysis was performed to determine the number
of components that exceeded what would be expected due to chance alone. Parallel analysis
estimates the number of components to include in a PCA model by generating random data
sets with the same numbers of observations and predictor variables as the original data.81
The eigenvalues are computed for each random data set and averaged over all the data sets.
When the average eigenvalue from these randomly generated data sets is larger than the
corresponding eigenvalue of the original data, then the principal component associated with
that eigenvalue is likely to be random noise.
After calculating the PCA eigenvectors, a promax rotation was applied to increase the
interpretability of the resulting PCA loadings. The promax rotation produced loadings that
were easier to interpret than the loadings resulting from orthogonal rotations, and other
nonorthogonal rotations produced similar results. The rotated loadings are presented unless
otherwise noted. The variance in the PCA loadings of each model was estimated by drawing
1,000 bootstrap samples for each data set and fitting a PCA model for each replicate. The
95% confidence bounds for the PCA loadings were estimated to be the 2.5% and 97.5%
quantiles of the corresponding loading over the 1,000 bootstrap replicates.24
Results
The overall goal of this manuscript (and the others in this compendium) is to present the
OPPERA methodology and to limit results in this initial report to general descriptive
findings from the baseline data collection phase. We believe the univariate data analytic
approach presented below accomplishes this most efficiently.
Case-Control Differences
Global Measures of Psychological Function (see Table 1 and Supplementary
e-Table 2)—As shown in Table 1, TMD cases had higher mean scores than controls across
all SCL-90R subscales of primary interest in this analysis: depression, somatization,
hostility, and anxiety. Mean scale scores in cases were almost two times the corresponding
mean for controls, and standardized odds ratios ranged from 1.4 for the Anxiety and
Hostility scales to 2.1 for the Somatization scale. Odds ratios and their 95% confidence
intervals were similar with and without adjustment for demographic characteristics, and
using imputed versus non-imputed data.
Regarding personality as measured by the EPQ-R, TMD cases showed higher levels of
neuroticism, on average, than controls, but no group differences in extraversion emerged.
The standardized odds ratio was 1.6 for Neuroticism, this value decreasing slightly to 1.5
after adjustment for demographic characteristics and to 1.4 using imputed data. The 95%
confidence intervals did not differ appreciably with or without adjustment for demographic
characteristics or using imputed data compared to the non-imputed data.
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Measures of Affective Distress (see Table 2 and Supplementary e-Table 3)—
Compared to controls, TMD cases reported higher mean levels of both state and trait anxiety
on the STAI. For both state and trait anxiety, standardized odds ratios were similar after
adjustment and when using imputed data rather than non-imputed data. On the POMS-Bi,
TMD cases reported higher Negative Affect and lower Positive Affect than controls.
Standardized odds ratios were 0.8 for Overall Positive Affect Score and 1.5 for Overall
Negative Affect Score. Odds ratios and their 95% confidence intervals were similar with and
without adjustment for demographic characteristics and when using imputed data.
Measures of Psychosocial Stress (see Table 2 and Supplementary e-Table 3)
—Relative to controls, TMD cases reported higher mean levels of perceived stress on the
PSS. Standardized odds ratios were similar with or without adjustment for demographic
characteristics, and when using imputed data versus non-imputed data. Data for the LES and
the LSL/PCL-C can be found in Supplementary e-Table 3.
Measures of Somatic Awareness (see Table 3 and Supplementary e-Table 4)—
PILL and Kohn scores, reflecting components of somatic awareness, were significantly
higher, on average, for TMD cases than controls. For PILL scores, standardized odds ratios
indicated a large difference between the groups (SOR=2.5), and the standardized odds ratios
were generally unaffected by adjustment for demographic characteristics or by use of
imputed versus non-imputed data. For Kohn scores, standardized odds ratios indicated
moderate group differences, and odds ratios were slightly lower after adjustment for
demographic characteristics and when using imputed rather than non-imputed data.
Measures of Coping/Catastrophizing (see Table 3 and Supplementary e-Table
4)—On the PCS, TMD cases had higher mean levels of catastrophizing than controls. This
was true for all three subscales (Rumination, Magnification, Helplessness) and standardized
odds ratios were similar across subscales, 1.5 for Magnification and Rumination and 1.6 for
Helplessness. The odds ratios and their 95% confidence intervals were similar with or
without adjustment for demographic characteristics and using non-imputed data or imputed
data.
For other measures of pain coping, assessed using the CSQ-R, small but significant case-
control differences emerged for Distraction and Praying & Hoping, with controls providing
higher values for both measures. Standardized odds ratios and their 95% confidence
intervals were unaffected by adjustment for demographic characteristics or by using imputed
data compared to the non-imputed data. No significant case-control differences emerged for
other CSQ-R scales.
Additional Measures (see Supplementary e-Table 5)—TMD patients on average
reported poorer overall sleep quality on the PSQI compared to controls. Also, on the SF-12,
Physical Component scores and Mental Component Scores were both lower (indicating
poorer function) for cases versus controls.
Associations with Demographic Variables (Controls only)
Global Measures of Psychological Function (see Supplementary e-Tables 6, 7
& 8)—As shown in Supplementary e-Tables 6, 7, and 8, female controls reported higher
mean scores on the SCL90R Depression and Somatization subscales; however, the effect
sizes for these gender differences were small. Mean Somatization scores were slightly and
significantly higher for the oldest participants. Significant ethnic group differences emerged
for Depression, Anxiety and Hostility, with higher mean values among the non-white group.
Regarding the EPQ-R, females reported greater mean levels of neuroticism than males, a
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difference of moderate effect size. Age groups differed in extraversion, with lower
extraversion associated with increasing age. Also, whites reported higher levels of
extraversion than non-whites.
Measures of Affective Distress (see Supplementary e-Tables 9, 10 & 11)—No
demographic group differences emerged for State Anxiety. For State and Trait Anxiety, non-
whites reported higher mean values than whites, and age was associated with Trait Anxiety,
such that the older group reported higher average scores. On the POMS-Bi, ethnic group
was associated with Positive Affect, such that whites higher scores than non-whites, though
the magnitude of the difference was small. A small but significant gender difference in
Negative Affect emerged, with women reporting greater values, on average.
Measures of Psychosocial Stress (see Supplementary e-Tables 9, 10 & 11)—
On the PSS, women reported higher mean levels of perceived stress than men, and non-
whites reported greater scores, on average, than whites. Age differences in PSS scores were
not significant.
Measures of Somatic Awareness (see Supplementary e-Tables 12, 13 & 14)—
Age, gender, and ethnic group differences in PILL scores were found, such that younger
participants, women, and non-Hispanic whites endorsed greater mean levels of somatic
symptomatology. These group differences were small in magnitude. Regarding Kohn scores,
significant age group, gender, and ethnic group differences emerged. Kohn scores were
greater with increasing age. Females reported higher scores than males, and non-whites had
greater values than whites.
Measures of Coping/Catastrophizing (see Supplementary e-Tables 12, A13 &
A14)—On the PCS, women reported higher mean scores than men for two of the subscales,
Rumination and Helplessness. Non-whites also reported higher mean levels on all three PCS
subscales than whites, though the magnitude of these mean differences was small. Age
differences in Helplessness scores emerged, with the oldest group reporting the highest
mean values. For other measures of pain coping, assessed using the CSQ-R, gender
differences were significant across most subscales. On average, women reported greater use
of Praying & Hoping, while men reported higher scores on Coping Statements, Ignoring
Pain Sensations and Reinterpreting Pain Sensations. Regarding ethnic group differences,
non-whites reported significantly greater use of Praying & Hoping, Distraction, and
Reinterpreting Pain Sensations, but lower mean values for Ignoring Pain. Age group
differences emerged for Praying & Hoping and Distraction, mean scores increasing with
greater age, and for Coping Statements, with lower mean scores in the oldest age group.
Principal Component Analysis—Figure 1 shows a scree plot of the PCA model for
controls. The variance explained by each component decreases to less than 10% after the
first four components. The parallel analysis showed strong evidence that components one
through four were above the chance line (See Figure 1). The confidence intervals for the
loadings of the first four components were generally very narrow, indicating a stable model.
While the five-component model also showed relatively narrow confidence intervals, the
four-component model appeared optimal based on the scree plot, the parallel analysis, and
on conceptual grounds. Thus, we report a model based on four components. The loadings for
the PCA model for controls are shown in Table 4, and the 95% confidence intervals for the
loadings are shown in Supplementary e-Table 15. The first component, accounting for 19%
of the variance, labeled Stress and Negative Affectivity, includes high loadings from both
State and Trait Anxiety, Perceived Stress, and POMS Negative Affect and negative loadings
for POMS Positive Affect and the EPQ-R extraversion Scale. Also the EPQ-R Neuroticism
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scale loads positively on this component. The second component, labeled Global
Psychological Symptoms, based on high loadings from all SCL-90-R scales, as well as the
PILL, accounted for an additional 16% of the variance. The third component, Passive Pain
Coping, accounted for an additional 14% of the variance. All three PCS subscales loaded
highly on this factor, as did the Praying and Hoping subscale of the CSQ-R. The Kohn score
loaded modestly on this component. The fourth component is labeled Active Pain Coping
and includes positive loadings from the remaining CSQ-R subscales. This final component
accounted for an additional 12% of the variance.
The loadings and 95% confidence intervals for the PCA for TMD cases are shown in
Supplementary e-Tables 16 and 17. These confidence intervals are much wider than
observed for controls. Indeed, with the exception of the loadings for the first component,
essentially all of the loadings for the PCA in cases have very wide confidence intervals. This
indicates that (with the exception of component one), this factor structure may not be
reproducible. The higher variance in the loadings of the cases PCA is probably due to its
much smaller sample size. The first component, accounting for 32% of the variance, reflects
Global Psychological Distress, based on positive loadings from all SCL-90-R scales, all
measures of affective distress (e.g. State & Trait Anxiety, POMS) as well as the PILL,
Perceived Stress Scale and the EPQ-R Neuroticism scale. The second component accounted
for an additional 16% of the variance and reflected Passive Coping and Reactivity. This
component included positive loadings from all three PCS subscales as well as the Praying
and Hoping subscale of the CSQ-R. Also, the Kohn score, a measure of reactivity to somatic
experiences, loaded positively on this component. The third component, Active Pain
Coping, accounted for an additional 10% of the variance and includes positive loadings from
the remaining CSQ-R subscales. The final component accounted for an additional 6% of the
variance, with positive loadings from POMS Positive Affect as well as the EPQ-R
Extraversion Scale. This component may reflect Psychological Resilience.
We calculated Cronbach’s alpha for each component (using items with a loading of 0.5 or
higher). The values of alpha ranged from 0.54 to 0.87 for the PCA in controls and from 0.45
to 0.93 for the PCA in cases.
Discussion
The findings above present the baseline psychosocial data from a large cohort of TMD-free
controls compared to a smaller group of individuals meeting research diagnostic criteria for
chronic TMD (i.e., cases). Significant case-control differences emerged across multiple
psychosocial content domains, such that TMD cases reported higher levels of psychological
and affective distress, greater perceived stress and catastrophizing, and increased somatic
awareness compared to controls. The case-control differences of greatest magnitude
emerged for measures of somatic awareness (i.e., PILL, SCL-90R Somatization), with
standardized odds ratios exceeding 2.0. In general, case-control differences for other
psychosocial variables were of more modest magnitude. These findings are consistent with
previous results of case-control studies examining psychosocial variables among individuals
with TMD8–10,13,29,47,48,50,51,61,67, as well as in studies of people with other types of
chronic pain.20,31,35 Less well-documented are the differences in pain coping that were
observed in this sample. Specifically, consistent with recent evidence8,67 TMD cases
reported higher levels of catastrophizing, a form of maladaptive cognitive appraisal that has
been associated with increased pain and disability across multiple chronic pain
conditions.22,79 Surprisingly, controls reported greater use of praying and hoping, which is
typically construed as a passive coping strategy, as supported by its loading with
catastrophizing in our PCA. It should be noted that the magnitude of this difference was
quite small, and the practical significance of this finding requires further investigation.
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From a methodological perspective, it is notable that cases and controls in the present study
were recruited from the same communities using similar recruitment approaches. This
avoids the sampling biases that can occur when cases are recruited from clinical settings and
controls are recruited from non-clinical sources. Such biases tend to inflate case-control
differences in psychological functioning, as many of these psychosocial variables are
associated with health care seeking in chronic pain populations.36,85 This may also explain
the modest magnitude of many of our case-control differences in psychological functioning,
as compared to what might be expected when contrasting community-based controls to
clinic cases.
Within controls, the association of demographic factors with psychosocial variables was
examined independently and without adjustment for other factors. In general, age-related
differences were small in magnitude and failed to follow a consistent pattern, perhaps owing
to the relatively restricted age range in our cohort. However, gender differences emerged for
multiple variables, with women reporting higher levels of psychological distress across
several SCL90-R scales, along with greater neuroticism, perceived stress, negative affect,
and somatic awareness. Women also reported greater use of catastrophizing, distraction and
praying & hoping, while men reported higher scores on coping self statements, and ignoring
and reinterpreting pain sensations. These gender differences are consistent with previously
published results,3,4,23,76 and the increased expression of these potential psychosocial risk
factors may contribute to the greater prevalence of TMD among women.42 Ethnic group
differences were also observed for several psychosocial measures, such that non-whites
reported higher psychological distress across all examined SCL90R subscales. Consistent
with previous findings32, ethnic differences in pain coping emerged, with significantly
greater use of catastrophizing, praying & hoping, distraction, and reinterpreting pain
sensations among non-whites. Regarding somatic awareness, ethnic differences emerged for
both the PILL and the Kohn, similar to previous results.68
That psychosocial factors differed significantly between cases and controls raises the
possibility that such psychosocial variables may represent predisposing risk factors for the
development of chronic pain. Of course, our present cross-sectional analysis cannot
determine the direction of the association; however, a limited literature has addressed
whether premorbid psychosocial factors are associated with subsequent development of
TMD. Members of this research group have reported that premorbid measures of depression,
perceived stress, and mood state obtained at baseline were significant predictors of new
onset TMD in a sample of healthy young females.75 Also, Aggarwal and colleagues1 found
that preexisting health anxiety predicted future development of chronic orofacial pain.
Similar findings supporting psychosocial variables as premorbid risk factors for
development of chronic pain have been reported for other chronic pain conditions, including
chronic widespread pain 53, regional musculoskeletal pain,57 and low back pain.43,44,57
While we are not able to address this issue in the present analysis of our baseline data, the
design of the OPPERA study will permit such analyses at the conclusion of the follow-up
period. For example, Aggarwal and colleagues reported that four psychosocial measures
distinguished cases from controls in univariate analyses; however, only health anxiety
remained a significant predictor in the multivariate approach.1 Therefore, our future analyses
to identify risk factors for new onset TMD will include multivariate approaches that
concurrently take into account multiple psychosocial measures, as well as potential
predictors from other domains.
Principal Component Analysis was implemented as an approach to operationalizing the
psychosocial component of the OPPERA heuristic model17 PCA revealed multiple latent
constructs based on the extensive battery of psychosocial measures. Among controls, the
four components reflected: (1) stress, anxiety, and neuroticism; (2) global psychological
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symptoms; (3) passive pain coping; and (4) active pain coping. The model was quite stable,
and the underlying constructs may reflect important sub-domains of the “enhanced
psychological distress” intermediate phenotype previously proposed in the OPPERA
conceptual model.49 Specifically, the PCA model indicates the presence of multiple aspects
of psychosocial function, which go beyond the unitary concept of “psychological distress.”
Indeed, the first two components seem to suggest that there are two different aspects of
“psychological distress,” one comprised primarily of personality characteristics and
affective distress (including anxiety and stress), and the other comprised of more global
psychological adjustment, including both somatic and psychological symptoms. That state
and trait anxiety load on the first component, while SCL90R Anxiety loads on the second
component is likely due to method variance, given that all of the other SCL90R scales also
loaded on component two. The last two components from the PCA model go beyond
“distress” and reflect different aspects of pain coping. In contrast to the psychological
symptoms reflected by the first two components, these coping components represent
cognitive and behavioral processes that may modulate the experience of pain and associated
psychological distress. Thus, the multiple constructs reflected by these components may
reflect important psychosocial domains for identifying individuals at risk for new onset
TMD pain. Among TMD cases, the underlying latent constructs identified in the present
study included: (1) global psychological distress; (2) passive pain coping and reactivity; (3)
active pain coping; and (4) psychological resilience. Given the difference in constructs
identified within the controls versus the cases, it is tempting to speculate that the underlying
structure of psychosocial constructs, as reflected by the component measures used in this
study, differs for individuals with chronic pain compared to those without. However, given
the instability of the PCA model in TMD cases, any potential case-control differences
should be interpreted with caution. Also, the latent variables identified by our PCA should
be viewed as exploratory, and further confirmation of these results will be needed. A logical
next step would be to determine the replicability of these findings in another sample.
Successful replication would increase confidence in the validity of the latent constructs
reflected by these components, such that indices representing these underlying constructs
could then be derived and used in future analyses designed to identify risk factors for new
onset TMD.
The limitations of this study deserve mention. First, relative to our large control population,
the sample size for cases is quite modest, which contributed to the instability of the PCA
model in cases and limited our ability to compare PCA models for cases versus controls.
Second, the analyses herein are restricted to the psychosocial data and do not examine
potentially important associations between psychosocial variables and other phenotypic
measures, such as those presented in other manuscripts in this volume. However, such
analyses are planned for future manuscripts. Third, given the large number of analyses
already presented, only univariate demographic comparisons were conducted, and the
pattern of findings from psychosocial variables may change when multiple psychosocial
measures are simultaneously considered using a multivariate approach. In future analyses, it
also will be informative to examine psychosocial measures stratified across multiple
demographic variables (e.g., age differences within each gender). Moreover, our analysis of
ethnic differences only considered whites versus non-whites, and future investigation of
different ethnic subgroups is warranted.
These limitations notwithstanding, the current findings demonstrate case-control differences
across multiple domains of psychosocial functioning, with the most robust differences
emerging for indices of somatic awareness. Moreover, our large sample of controls provided
statistical power for demographic comparisons, which revealed gender and ethnic group
differences for multiple psychosocial variables. Similar to recently reported findings from
healthy subjects,56 our PCA suggests that these multiple psychosocial measures can be
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reduced to a smaller subset of latent constructs. Future analyses will examine associations of
these psychosocial variables with other important phenotypes, such as quantitative sensory
testing data and clinical examination findings. Further, genetic associations with
psychosocial variables will be explored in future work. Finally, the ultimate goal of
collecting these psychosocial measures is to determine their ability to predict new onset of
TMD, and these analyses will be conducted upon completion of the follow-up phase of the
OPPERA Study.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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This article reports baseline psychosocial findings from the OPPERA Study, a large
prospective cohort study designed to discover causal determinants of TMD pain.
Findings indicate significant differences between TMD cases and TMD-free controls
across multiple psychosocial constructs, and future analyses will determine whether these
psychosocial factors increase risk for new onset TMD.
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Scree plot and parallel analysis from PCA. The vertical lines depict the eigenvalues for each
scomponent, showing a significant drop off after component 4. Also, the open triangles and
solid black line show the upper bound of the 95% confidence interval for eigenvalues that
would be expected for each component from a PCA computed on a random data set. As can
be seen, the observed eigenvalues for the first 4 components exceed the chance line, further
supporting the selection of a 4 component model.
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